» Articles » PMID: 21190503

The Prevalence of and Risk Factors for Acute Mountain Sickness in the Eastern and Western Alps

Overview
Date 2010 Dec 31
PMID 21190503
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Acute mountain sickness (AMS) is the most common condition of high altitude illnesses. Its prevalence varies between 15% and 80% depending on the speed of ascent, absolute altitude reached, and individual susceptibility. Additionally, we assumed that the more experienced mountaineers of the Western Alps are less susceptible to developing AMS than recreational mountaineers of the Eastern Alps or tourist populations. Therefore, the main goals of the present study were the collection of data regarding the AMS prevalence and triggers in both the Eastern and Western Alps using identical methods. A total of 162 mountaineers, 79 in the Eastern Alps (3454 m) and 83 in the Western Alps (3817 m) were studied on the morning after their first night at high altitude. A diagnosis of AMS was based on a Lake Louise Score (LLS) ≥4, the presence of headache, and at least one additional symptom. Thirty of 79 subjects (38.0%) suffered from AMS at 3454 m in the Eastern Alps as did 29 of 83 (34.9%) at 3817 m in the Western Alps. After adjustment for altitude, the prevalence in the Western Alps constituted 24.5%, which differed significantly (p = 0.04) from that found in the Eastern Alps. The lower mountaineering experience of mountaineers in the Eastern Alps turned out to be the only factor for explaining their higher AMS prevalence. Thus, expert advice by mountain guides or experienced colleagues could help to reduce the AMS risk in these subjects.

Citing Articles

Risk factors associated with high altitude sickness among travelers: A case control study in Himalaya district of Nepal.

Poudel S, Wagle L, Ghale M, Aryal T, Pokharel S, Adhikari B PLOS Glob Public Health. 2025; 5(2):e0004241.

PMID: 39919099 PMC: 11805385. DOI: 10.1371/journal.pgph.0004241.


Mountain sickness in altitude inhabitants of Latin America: A systematic review and meta-analysis.

Zila-Velasque J, Grados-Espinoza P, Goicochea-Romero P, Tapia-Sequeiros G, Pascual-Aguilar J, Ruiz-Yaringano A PLoS One. 2024; 19(9):e0305651.

PMID: 39316567 PMC: 11421813. DOI: 10.1371/journal.pone.0305651.


Prevalence and knowledge about acute mountain sickness in the Western Alps.

Berger M, Husing A, Niessen N, Schiefer L, Schneider M, Bartsch P PLoS One. 2023; 18(9):e0291060.

PMID: 37708123 PMC: 10501682. DOI: 10.1371/journal.pone.0291060.


Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?.

Burtscher J, Swenson E, Hackett P, Millet G, Burtscher M J Travel Med. 2023; 30(4).

PMID: 36694981 PMC: 10289512. DOI: 10.1093/jtm/taad011.


High-altitude illnesses: Old stories and new insights into the pathophysiology, treatment and prevention.

Burtscher M, Hefti U, Pichler Hefti J Sports Med Health Sci. 2022; 3(2):59-69.

PMID: 35782163 PMC: 9219347. DOI: 10.1016/j.smhs.2021.04.001.